On Tuesday, Ingevity got an upgrade to its Relative Strength (RS) Rating, from 70 to 74.
This unique rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks compares to the rest of the market.
Over 100 years of market history shows that the market's biggest winners often have an 80 or higher RS Rating as they launch their largest climbs. See if Ingevity can continue to rebound and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Ingevity is trying to complete a cup with handle with a 51.67 buy point. See if it can clear the breakout price in heavy trading.
Although earnings and sales growth came in at -9% and -15%, respectively, in the latest report, that means earnings have improved for the last three reports and revenue has increased for one.
The company holds the No. 19 rank among its peers in the Chemicals-Specialty industry group. Air Products & Chemicals, Luxfer Holdings and Cabot Corp are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
